Notable insider buying and selling activity across public companies.
Tracking and analysis of reported insider transactions, including executive and director buying or selling. Insider activity can offer insight into internal confidence, valuation perceptions, and potential inflection points.
13,183 total articles
Kirby Corp Chief Executive David W. Grzebinski sold 34,152 shares on February 24, 2026, for roughly $4.44 million after exercising options for the same number of shares. The move comes amid a recent 32% share-price gain over six months, a fourth-quarter 2025 earnings beat on EPS but a revenue miss, and the board nomination of Tracy A. Embree as an …
Rollins Inc. executive Elizabeth B. Chandler sold 14,201 shares on February 25, 2026, for $59.36 per share under a Rule 10b5-1 plan, generating $842,971 in proceeds. The transaction occurred near the stock's trading level and follows the company's fourth-quarter fiscal 2025 results, which slightly missed analyst forecasts and prompted divergent pri…
Lawrence B. Seidman, a director of Bankwell Financial Group, Inc. (NASDAQ: BWFG), acquired $473,962 worth of common stock on February 23, 2026. The purchases, executed at prices between $47.39 and $47.42 per share, were made through several entities affiliated with Seidman. The insider buying occurred while BWFG traded at $48.32 and after the compa…
Voyager Therapeutics CFO Nathan D. Jorgensen executed a pre-arranged automatic sale of 4,668 shares on February 24, 2026, to satisfy tax withholding tied to restricted stock units that vested days earlier. The shares were sold for $17,598 at prices between $3.61 and $3.86. The company’s stock has since climbed roughly 20% over the last week and is …
Voyager Therapeutics Chief Operating Officer Robin Swartz completed a pre-arranged, automatic sale of 6,458 shares on February 24, 2026, to satisfy tax withholding tied to restricted stock units that vested earlier in the month. The transaction, reported on a Form 4, generated about $24,346 and followed a near 20% surge in the stock over the prior …
Voyager Therapeutics President and CEO Alfred Sandrock sold 14,197 shares of common stock on February 24, 2026, raising $53,806 at prices between $3.61 and $3.86 per share. The sale, executed under a pre-arranged automatic instruction adopted May 12, 2025, was carried out to satisfy tax withholding obligations tied to restricted stock units that ve…
Voyager Therapeutics Chief Scientific Officer Todd Alfred Carter completed a pre-arranged sale of 4,174 common shares on February 24, 2026, to satisfy tax withholding tied to restricted stock units. The transaction, executed under an automatic sale instruction adopted in May 2025, generated proceeds of $15,694 at a weighted average price of $3.76. …
Director Eric Sachetta acquired 2,000 shares of Sensus Healthcare, Inc. (NASDAQ: SRTS) on February 24, 2026, at $3.81 per share for a total of $7,620, bringing his direct holdings to 142,113 shares. The transaction was disclosed on a Form 4 filed with the Securities and Exchange Commission. The company recently posted Q4 2025 results that missed fo…
Ideal Power President and CEO David M. Somo acquired 90,909 common shares on February 25, 2026, for $2.75 per share, an investment of roughly $250,000. The transaction leaves Somo with 338,347 shares directly owned. The purchase follows a six-month decline in the stock of 34%, with shares recovering to $3.23, about 17% above Somo's purchase price. …
Brian J. Caveney, Executive Vice President at Labcorp Holdings Inc (NYSE: LH), sold 1,500 shares of common stock on February 24, 2026 for $286.305 per share, generating proceeds of $429,457. The transaction took place while the stock was trading close to its 52-week high of $293.72 and amid analyst price targets ranging from $260 to $342. Following…
Insulet Corp director Michael R. Minogue bought 2,030 shares on February 25, 2026, paying a weighted average of $246.23 for a total of $499,846. The purchase occurs while the stock trades near $248.12 and InvestingPro flags the shares as undervalued relative to Fair Value. The medical device maker reported $784 million in fourth-quarter 2025 revenu…
Jude Schramm, Executive Vice President and Chief Information Officer of Fifth Third Bancorp (NASDAQ: FITB), executed a series of transactions on February 23 and 24, 2026 that included the sale of 11,396 shares for $757,514, the exercise of stock appreciation rights for 14,228 shares valued at $380,172, and the disposition of 10,332 shares to cover …
Avnet CEO Philip R. Gallagher sold 46,068 shares of company stock on February 24, 2026, for roughly $3.1 million while exercising options to acquire 46,068 shares the same day. The trades occurred as Avnet's shares have climbed about 40% year-to-date and following quarterly results that beat earnings and revenue forecasts.
Hans Erik Vestberg, a director of Verizon Communications Inc. (VZ), sold 225,000 shares of the company's common stock on February 24, 2026, for proceeds totaling $11,163,150. The transaction - executed across prices from $49.395 to $49.865 per share - took place with Verizon trading close to a 52-week high of $50.48 following an almost 23% year-to-…
DT Midstream Executive Vice President and CFO Jeffrey A. Jewell purchased 185 shares of the company's common stock on February 25, 2026, for $136.33 apiece, a transaction valued at $25,221. After the purchase Jewell holds 89,582.78 shares. The company’s fourth-quarter 2025 results were mixed - EPS of $1.08 missed the $1.17 forecast while revenue of…
Williams Companies SVP and General Counsel Terrance Lane Wilson sold 27,000 shares on February 24, 2026 for about $1.97 million after exercising options the previous day. The filings show option exercises, issuer share withholdings for tax obligations, and an updated post-transaction ownership stake. The company has also seen fresh analyst price-ta…
IBM director Michelle J. Howard purchased 50 shares of International Business Machines Corp. on February 25, 2026, paying $237.83 per share for a total of $11,891. The trade leaves her with 194 shares directly held. The purchase takes place while IBM shares have fallen 19% year-to-date and recently edged down 7.3% over the prior week, trading close…
Michael Dean Brown, Director and President & CEO of Travel & Leisure Co. (NYSE: TNL), sold common stock on February 23-24, 2026, totaling $6.89 million and exercised options to acquire additional shares at an exercise price of $44.38 for a cumulative value of $4,118,375. After these moves, Brown directly holds 427,821 shares. Separately, Travel + L…
Gabrielle B. Toledano, a director at IonQ, Inc. (NASDAQ: IONQ), sold 616 shares on February 24, 2026, for $19,096 at $31 per share under a Rule 10b5-1 plan. The stock has since traded up to $33.59 but remains about 25% lower year-to-date. IonQ reported stronger-than-expected fourth-quarter 2025 results, with EPS of -$0.20 compared with an expected …
Carter Deon, Vice President and President CAPV of Olin Corp, sold 6,500 shares of company stock on February 25, 2026, for roughly $154,225. The transaction, disclosed on a Form 4 filing with the SEC, comes amid a wave of analyst rating actions and price-target cuts driven by a weaker earnings outlook for 2026 across key Olin business lines.
Moderna President Stephen Hoge sold 160,009 shares on February 23, 2026, at $48.84 per share under a Rule 10b5-1 plan, realizing roughly $7.8 million, and exercised options to acquire the same number of shares at $19.15. The moves come while Moderna shares hover near a 52-week high following a substantial six-month rally, and after the company repo…
Vikram Gupta, Senior Vice President at Synaptics Incorporated (NASDAQ: SYNA), sold 772 shares on February 25, 2026, for approximately $62,972 at $81.57 per share under a 10b5-1 plan. After the transaction Gupta holds 95,996 shares. Separately, Synaptics posted Q2 fiscal 2026 results that topped analyst estimates on both EPS and revenue, yet the sto…
Coliseum Capital Management and related entities purchased a total of $9.14 million in Sonos Inc. (SONO) common stock in multiple transactions executed between February 23 and February 25, 2026. The acquisitions - executed at prices between $14.53 and $15.40 per share - increased the combined holdings of the firms and named individuals to 16,921,84…
Blackbaud Inc.'s Executive Vice President and Chief Technology Officer, Kevin McDearis, sold 15,462 shares on February 23, 2026, in two transactions totaling roughly $717,850, according to a Form 4 filing. The filing also records shares issued from vesting of performance-restricted units and shares sold to cover tax obligations. These moves come as…
Blackbaud executive vice president and chief commercial officer David J. Benjamin sold 14,349 shares on February 24, 2026, generating approximately $681,108. The Form 4 filing shows additional February 23 disposals to meet tax obligations, the vesting of performance restricted stock units, and an unchanged post-transaction holding of 73,124 shares.…
